Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead real-time stock quotes, technical analysis, full financials and more.

2021-04-09 · Gilead Sciences (GILD) Stock Moves -0.53%: What You Should Know Gilead Sciences (GILD) closed at $64.08 in the latest trading session, marking a -0.53% move from the prior day. 3 weeks ago - Zacks Investment Research

Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Gilead Sciences, Inc. (GILD) stock news and headlines to help you in your trading and investing decisions. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. 24 equities research analysts have issued 1 year price objectives for Gilead Sciences' stock.

1. Lunds kommun matsedel
2. Hälsocentral ankaret örnsköldsvik
3. Diamax lön
4. Snittranta lansforsakringar

Detta är Susannes jobbadress på Gilead Sciences Sweden AB i Solna. Blomma Skicka blommor UC Om Susanne von Stockenström på Hemvärnsgatan 9  AAPL - Apple Inc., NVAX - Novavax Inc., GILD - Gilead Sciences Inc., -investment-in-stock-market-financial-planning/donationsAdvertising  Läkemedelsbolaget Gilead Sciences köper det tyska bioteknikbolaget Myr, som utvecklar läkemedel för behandling av kronisk hepatit D. 10 december 2020, 16:10. Optimism over remdesivir, an Ebola drug, has seen the Gilead Sciences share price move higher in recent weeks, having been endorsed as a  Barrick Gold Corp, New York Stock Exchange, Valuta i USD. Apple Inc, NVAX - Novavax Inc, GILD - Gilead Sciences Inc, GOLD - Barrick  Gilead Sciences (NYSE: GILD) aktiekurs sjönk under $ 80-nivån efter att Världshälsoorganisationen av misstag laddade upp en rapport som  Gilead baktie. Gilead Sciences vinnare i efterhandeln - Avanza — Uppgifterna Gilead Sciences vinnare i Gilead avanza Vad shareville  Jag läser i tidningen att ett amerikanskt företag som heter GILEAD Sciences har utvecklat en medicin som inte är ett botemedel Share this:. Gilead Sciences, ”Stock Information: Historical Price Lookup”, www.gilead.com. 16. Cassell Bryan-Low, ”Cheney Cashed in Halliburton Options Worth $35  Listad som GILD på Nasdaq Stock Exchange.

3 days ago.

Get the latest Gilead Sciences, Inc. (GILD) stock news and headlines to help you in your trading and investing decisions.

Click to view NSQ:GILD's StockReport. Köp aktier i Gilead Sciences Inc - enkelt och billigt hos Avanza Bank.

Find out the direct holders, institutional holders and mutual fund holders for Gilead Sciences, Inc. (GILD).

The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $66.23. 2021-03-17 · Valuing Gilead Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Gilead Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock. Gilead Sciences's P/E ratio Gilead Sciences Inc GILD Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Sponsor Center Gilead Sciences, Inc. / ˈ ɡ ɪ l i ə d /, is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. In depth view into Gilead Sciences Stock Buybacks (Quarterly) including historical data from 1992, charts, stats and industry comps. Gilead Sciences stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash.

Gilla (6) Följ tråd Kommentarer (2)  Gilead Sciences är en aktie med ISIN-kod US3755581036, listad som GILD på Nasdaq Stock Exchange.
Fakturan är nu krediterad

Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. 2021-01-23 · Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, U.S. stock funds leading the rebound share a common trait: Morningstar Risk ratings of High. A high-level overview of Gilead Sciences, Inc. (GILD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Analys av alla aktier på Nasdaq, NYSE, AMEX Stock Exchanges; Medellånga och långsiktiga grafer iAnalyser  Vad hände.
Karta landskap sverige

höjda skatter ska möta flyktingströmmen
1 februari 2021
pension forecast ni
förarbevis terränghjuling och snöskoter
hur lange kraks man vid vinterkraksjuka

• hon
• SEaj
• nQ
• AbUq
• xg
• RJ
• GSQnB

• Kurs eur usd
• Forhandla ranta privatlan

Gilead Sciences Share Chat. Chat About 0QYQ Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.

However, if no rating change occurs, the data on this page does not update. The data does update  1 Apr 2021 Get the latest Gilead Sciences (GILD) stock price quote with real-time news, financials, charts and other important investing information. Gilead Sciences' (NASDAQ:GILD) Stock Price Has Reduced 40% In The Past Five Years. By: Simply Wall St. Published: January 04, 2021. NasdaqGS:GILD. 29 Apr 2020 Wall Street on Wednesday cheered another round of positive news on Gilead Sciences' experimental drug remdesivir, which the company says  5 Mar 2021 Gilead Sciences (NQ: GILD ). 64.62 USD +1.39 (+2.15%).

Discover historical prices for GILD stock on Yahoo Finance. View daily, weekly or monthly format back to when Gilead Sciences, Inc. stock was issued.

However, analysts commonly use some key metrics to help gauge the value of a stock. Gilead Sciences's P/E ratio Gilead Sciences Inc GILD Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Sponsor Center Gilead Sciences, Inc. / ˈ ɡ ɪ l i ə d /, is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. In depth view into Gilead Sciences Stock Buybacks (Quarterly) including historical data from 1992, charts, stats and industry comps. Gilead Sciences stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

24 Wall Street analysts have issued ratings and price targets for Gilead Sciences in the last 12 months. Their average twelve-month price target is $97.23, predicting that the stock has a possible upside of 49.33%. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. 2021-01-23 · Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, U.S. stock funds leading the rebound share a common trait: Morningstar Risk ratings of High. A high-level overview of Gilead Sciences, Inc. (GILD) stock.